Entezari, Morteza <br/><br/>
Combination of intravitreal bevacizumab and erythropoietin versus intravitreal bevacizumab alone for refractory diabetic macular edema: a randomized double-blind clinical trial.  [electronic resource] 

 -  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie  Nov 2019 
 - 2375-2380 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1435-702X 
<br/><br/><label>Standard No.: </label>10.1007/s00417-019-04383-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angiogenesis Inhibitors--administration & dosage<br/>Bevacizumab--administration & dosage<br/>Diabetic Retinopathy--complications<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Erythropoietin--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Intravitreal Injections<br/>Macula Lutea--pathology<br/>Macular Edema--diagnosis<br/>Male<br/>Middle Aged<br/>Tomography, Optical Coherence--methods<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors